secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072878
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth amends warrants and preferred stock certificates to remove anti-dilution price adjustments
--------------------------------------------------------------------------------

- Removed provision in May 1, 2023 warrants that adjusted exercise price upon future equity raise below $3.334 per share.
- Amended Series B, B-1, B-2, B-3 preferred stock certificates to eliminate conversion price adjustment in case of subsequent equity sale below $3.00 floor.
- Removed 19.99% blocker from Series B, B-2, B-3 certificates; Series B-2 dividend shares subject to stockholder approval.
- No new securities issued; changes solely to remove adjustment triggers that could dilute existing holders.
- Effective June 14, 2023; filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923072878/0001104659-23-072878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923072878/tm2318898d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer